These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23009247)
1. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. Lipsky BA; Moran GJ; Napolitano LM; Vo L; Nicholson S; Kim M BMC Infect Dis; 2012 Sep; 12():227. PubMed ID: 23009247 [TBL] [Abstract][Full Text] [Related]
2. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Garau J; Ostermann H; Medina J; Avila M; McBride K; Blasi F; Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184 [TBL] [Abstract][Full Text] [Related]
3. Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study. Garau J; Blasi F; Medina J; McBride K; Ostermann H; BMC Infect Dis; 2015 Feb; 15():78. PubMed ID: 25879713 [TBL] [Abstract][Full Text] [Related]
5. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973 [TBL] [Abstract][Full Text] [Related]
6. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors. Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685 [TBL] [Abstract][Full Text] [Related]
7. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study. Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. Zervos MJ; Freeman K; Vo L; Haque N; Pokharna H; Raut M; Kim M J Clin Microbiol; 2012 Feb; 50(2):238-45. PubMed ID: 22116149 [TBL] [Abstract][Full Text] [Related]
9. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria. Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections. Takimoto K; Wang Q; Suzuki D; Katayama M; Hayashi Y Expert Opin Pharmacother; 2017 Jul; 18(10):1027-1034. PubMed ID: 28627952 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study. Gonzalez-Ruiz A; Beiras-Fernandez A; Lehmkuhl H; Dohmen PM; Loeffler J; Chaves RL Int J Antimicrob Agents; 2013 Apr; 41(4):372-8. PubMed ID: 23499225 [TBL] [Abstract][Full Text] [Related]
12. Skin and soft-tissue infections: modern evolution of an ancient problem. Spellberg B Clin Infect Dis; 2010 Oct; 51(8):904-6. PubMed ID: 20839952 [No Abstract] [Full Text] [Related]
14. Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013. Li X; Chen Y; Gao W; Ouyang W; Wei J; Wen Z PLoS One; 2016; 11(2):e0149960. PubMed ID: 26918456 [TBL] [Abstract][Full Text] [Related]
15. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study. Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J; J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206 [TBL] [Abstract][Full Text] [Related]
16. Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections. Knapp AG; Kamepalli RK; Martone WJ; Yankelev S Surg Infect (Larchmt); 2011 Apr; 12(2):113-8. PubMed ID: 21348765 [TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study. Bogner JR; Kutaiman A; Esguerra-Alcalen M; Heldner S; Arvis P Adv Ther; 2013 Jun; 30(6):630-43. PubMed ID: 23797470 [TBL] [Abstract][Full Text] [Related]
18. Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting. Hurley HJ; Knepper BC; Price CS; Mehler PS; Burman WJ; Jenkins TC Am J Med; 2013 Dec; 126(12):1099-106. PubMed ID: 24262724 [TBL] [Abstract][Full Text] [Related]
19. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621 [TBL] [Abstract][Full Text] [Related]
20. Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden. Jääskeläinen IH; Hagberg L; From J; Schyman T; Lehtola L; Järvinen A Clin Microbiol Infect; 2016 Apr; 22(4):383.e1-383.e10. PubMed ID: 26806138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]